Indefinite Delivery Contract HHSF223201710005I

Award Date 2/21/17
Last Date to Order 4/20/20
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian federal agency, to Iqvia Government Solutions Inc., a for-profit organization specializing in healthcare data, analytics, and research services. The contract has a ceiling value of $4,463,492.67 and a period of performance extending to July 14, 2030. The primary objective of this contract is to provide the FDA with comprehensive hospital inpatient and emergency department drug...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) valued at $45 million to Iqvia Government Solutions Inc., a leading provider of healthcare data, analytics, and related services to federal agencies. The contract enables the FDA to issue task orders for access to outpatient prescription and patient-level drug utilization data to support its regulatory programs and post-market drug safety monitoring initiatives over a...
The Department of Health and Human Services Food and Drug Administration awarded a single award indefinite delivery contract to Iqvia Government Solutions Inc. to provide hospital drug utilization data and regulatory drug utilization services. The base period of performance is from March 2020 through March 2025 with a potential value of $9 million. Under the first delivery order valued at $3.667 million, Iqvia will deliver hospital drug data from Silver Spring, Maryland through April 2025. The...
The Indefinite Delivery Contract (IDC) with ID 75F40118D10032 was awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc. under the Biologics Effectiveness and Safety (BEST) Initiative. The $75 million multiple-award contract aims to develop new and innovative methods for automated reporting of CBER-regulated biological products. Iqvia Government Solutions, a leading provider of healthcare data and analytics services to federal agencies, will deliver a range of...
This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Iqvia Government Solutions Inc., a prominent healthcare data and analytics provider. The contract, valued at up to $3,169,963.15, provides the FDA with access to over-the-counter (OTC) drug utilization data to strengthen the agency's drug monitoring and safety surveillance programs. Through a series of firm fixed price delivery...
This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $10 million IDC provides data licensing, data acquisition and management, and drug use surveillance services to support the FDA's post-marketing surveillance of non-medical use of pharmaceuticals and use of illicit drug substances. Two task orders have been issued under this IDC. The...
The federal contract IDV award with ID 75F40118D10007 is an Indefinite Delivery Contract (IDC) issued by the Food and Drug Administration (FDA), a civilian agency, to Syneos Health Research & Insights LLC, a for-profit limited liability company. The contract has a ceiling value of $2,947,016.61 and a period of performance running from the award date of May 16, 2018 to the ultimate completion date of May 16, 2023. The contract is for "ACCESS TO HEALTH CARE PRACTITIONER PRESCRIBING...
This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Ihrc, Incorporated, a small disadvantaged and woman-owned business. The $49.5 million contract provides the FDA with specialized technical services to support safety, occupational health, and laboratory operations across its facilities. Key services include safety engineering, industrial hygiene, laboratory science, laboratory security, and occupational health support. The...
The Federal Contract IDV award is a single-award Indefinite Delivery Contract valued at up to $3,446,837.42 for a period of performance from May 16, 2023 to May 16, 2026. The contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Syneos Health Research & Insights LLC. The contract aims to provide the FDA with access to healthcare practitioner prescribing practices data. The original solicitation was a combined synopsis/solicitation for commercial items,...
This Indefinite Delivery Contract was awarded by the Food and Drug Administration (FDA), a civilian agency, to Circana, LLC (doing business as Infoscan), a for-profit data and analytics firm. The single-award $20,001,000.00 Indefinite Delivery Indefinite Quantity (IDIQ) contract runs from April 2, 2024 through April 1, 2029 and serves as a comprehensive vehicle for the FDA and potentially other federal partners to access Circana's consumer insights, data, and analytics services through...

This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Iqvia Government Solutions Inc., a for-profit provider of advanced analytics, technology solutions, and clinical research services. The contract, valued at up to $2,397,717.80, is for ACCESS TO HOSPITAL INPATIENT AND EMERGENCY DEPARTMENT DRUG UTILIZATION DATA. This single-award IDC, which does not include any set-asides, will run through April 20, 2020.

Iqvia Government Solutions Inc. is an experienced federal contractor, holding several prime IDVs with agencies like HHS and the Department of the Army. Under this contract, Iqvia will provide the FDA with access to hospital inpatient and emergency department drug utilization data to support the agency's post-market drug safety monitoring and surveillance efforts. This data, sourced from Iqvia's extensive healthcare databases, will enhance the FDA's ability to analyze prescription drug usage patterns and trends across different care settings.

Generated 7/10/24, 9:13 AM